Sign in

CIK 0001133869

  • Non-accelerated filer
  • Smaller reporting company

CAPRICOR THERAPEUTICS, INC.

Sign in to watch
Ticker
CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 310-358-3200
Business address
10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
Former names
Nile Therapeutics, Inc., SMI PRODUCTS INC
  1. 4 Open-market buy Director bought 197,628 shares
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Director bought 510 shares at $0.75 ($383)
  4. 4 Open-market buy Chief Financial Officer bought 11,000 shares at an average $0.76 ($8,370)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Director bought 3,100 shares at $1.15 ($3,565)
  14. 4 Open-market buy Director bought 2,500 shares at $1.15 ($2,875)
  15. 4 Open-market buy Director bought 2,500 shares at $1.05 ($2,625)
  16. 4 Open-market buy Director bought 6,500 shares at an average $1.31 ($8,495)
  17. 4 Open-market buy Chief Executive Officer bought 3,000 shares at an average $0.86 ($2,580)
  18. 4 Open-market buy Chief Financial Officer bought 4,186 shares at an average $0.83 ($3,480)
  19. 4 Open-market buy Director bought 4,600 shares at an average $1.19 ($5,483)
  20. 4 Open-market buy Director bought 8,200 shares at an average $1.13 ($9,284)

Page 16 of 18 · 345 filings